DexCom (NASDAQ:DXCM) Posts Earnings Results, Beats Expectat

DexCom (NASDAQ:DXCM – Get Free Report) released its quarterly earnings data on Thursday. The medical device company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05, reports. DexCom had a return on equity of 31.38% and a net margin of 16.82%. The firm had revenue of $921.00 million […]

Related Keywords

United States , Jacob Steven Leach , Matthew Vincent Dolan , Raymond James , Lindbrook Capital , Slatestone Wealth , Canaccord Genuity Group , Wealth Solutions , Financial Planning Inc , Dexcom Company Profile , Dexcom Inc , Citigroup , Get Free Report , Steven Leach , Vincent Dolan , Stone Wealth , Financial Planning , Genuity Group , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Earnings ,